Abstract: Proper contrast change can improve the perceptual quality of most images, but it has largely been overlooked in the current research of image quality assessment (IQA). To fill this void, we ...
MRI contrast agents, especially gadolinium-based ones, can improve diagnostic accuracy but also carry potential health risks. Updated clinical recommendations emphasize careful patient selection, dose ...
A JAMA study of nearly 500 men with suspected prostate cancer examines that question. Catch up with what else physicians are reading in JAMA Network journals. Magnetic resonance imaging (MRI) with or ...
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best medical device stocks to invest in right now. Piper Sandler cut the price target on GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best NASDAQ stocks with the highest upside potential. On April 23 ...
On April 18, Andrew Slimmon, Managing Director & Senior Portfolio Manager at Morgan Stanley Investment Management, appeared ...
GE HealthCare doses first patient in phase 2/3 LUMINA trial for manganese-based MRI contrast agent, mangaciclanol: Chalfont St Giles,?UK Saturday, April 25, 2026, 12:00 Hrs [IST] ...
GE HealthCare (Nasdaq: GEHC) today announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) ...
CEA, INAC, Service de Chimie Inorganique et Biologique (UMR_E 3 CEA UJF, FRE 3200 CNRS), 38054 Grenoble, France and CEA, iRTSV, Laboratoire Chimie et Biologie des Métaux (UMR 5249 CEA CNRS UJF), ...
Abstract: Underwater images suffer from various quality degradation problems such as color cast, low contrast, and blurred details. To solve these issues, a novel underwater image enhancement method ...